$345 Million

Mirati Therapeutics

Follow-on Offering

Bookrunner, January 2020

Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products.